http://www.healthimaginghub.com/article/1592-lantheus-to-provide-definity-in-india.html
Health Imaging Hub was initiated by radiologists, health imaging technologists, and internet media experts to promote Health Imaging and IT Globally with an emphasis of regional coverage.
Monday, 19 July 2010
Lantheus To Provide DEFINITY In India
Lantheus Medical Imaging, Inc., a leading company offering diagnostic imaging solutions, announced that it has
provided its DEFINITY® Vial, an ultrasound contrast imaging agent, in the market in India. Lantheus has closed a deal with J.B. Chemicals & Pharmaceuticals, Ltd. (JBCPL), a major company located in Mumbai,to distribute and market DEFINITY in India. DEFINITY, a Perflutren Lipid Microsphere ultrasound contrast agent, is already available in markets of Australia, New Zealand in addition to North America and several countries in the Middle East. In India, DEFINITY® is indicated for patients with suboptimal echocardiograms, as it opacifys the left ventricle in addition to enhancing the delineation of the left ventricular endocardial border, it can also be sued in patients for contrast-enhanced diagnostic ultrasound imaging for better reviewing of focal lesions of the kidney and liver.
http://www.healthimaginghub.com/article/1592-lantheus-to-provide-definity-in-india.html
http://www.healthimaginghub.com/article/1592-lantheus-to-provide-definity-in-india.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment